
American Express exited the financial planning service after participating in two funding rounds over the last two years.
Iris Capital has agreed to exit the communication and management services provider by divesting its stake to employee services provider Edenred.
Seven months after its launch, Google-backed social network Rekindle has been acquired for an undisclosed amount by HubSpot.
The KDDI-backed media curation app developer has filed for an initial public offering that will reportedly value it at about $335m.
Antibody developer XO1, backed by a Johnson & Johnson-backed fund, has been acquired by another Johnson & Johnson subsidiary, Janssen Parmaceuticals.
Hearst and Amazon both exited the revenue management company after it was acquired by AppNexus, which will integrate its technology into its own platform.
Pfizer-backed Cellectis, which is developing cancer treatments, will issue 3.5 million shares and could raise about $129m.
Pulmatrix, an inhaled drug developer that had raised $65m in venture funding, will be acquired by publicly-listed Ruthigen in an all-share deal.
Seachaid Pharmaceuticals-backed Cidara, which is developing therapies to treat fungal infections, has raised $74m in the past two years.